(Last updated : 2020-04-28 16:02:34)
  山根 弘路
   Department     ,
   Position  
■ BooK
1. 2016/01   Present issues of cancer survivorship in Japan「月刊 血液内科」 
2. 2011/09   “Hairy morphology” of hairy cell leukemia-Japanese variant may disappear under specific conditions, BloodMed 
3. 2011/07   HHV8- unrelated primary effusion lymphoma- like lymphoma in an elderly man, BloodMed 
4. 2011/06   Asian intravascular B-cell lymphoma relapsing in both adrenal glands simultaneously., BloodMed 
■ Journal
1. 2011/05 Synchronous double primary lung cancers with different response to pemetrexed. 
2. 2011/07 CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. 
3. 2011/07 An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report. 
4. 2011/10 Spontaneous regression of pulmonary pure ground-glass opacity with progression of a solid component during a 40-month follow-up 
5. 2011/10 Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer. 
Display all(54)
■ Presentation
1. 2014/04/27 Circulating TARC/CCL17 is a possible diagnostic marker for interstitial lung disease (ILD) in patients with non-small cell lung cancer (NSCLC)  
2. 2018/07/20 Patients with osteosarcoma and soft tissue sarcoma tend to become cancer refugees in
Japanese regional cities  
3. 2016/04/20 Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer  
4. 2015/10/08 Two Newly Discovered Mechanisms of Acquired Resistance to the Selective ALK Inhibitor Alectinib in Lung Cancer  
5. 2015/04/20 Both Programmed cell death protein 1 and programmed death-ligand 1 molecules can be expressed on the surface of small-cell lung cancer  
Display all(6)